StockData

CapsoVision vs QT Imaging

CV and QTI side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CV and QTI compare

CapsoVision is the larger company, worth 10 times as much as QT Imaging ($314M against $30.2M).

QT Imaging grew revenue faster over the last twelve months (157% versus 6.4% for CapsoVision).

QT Imaging keeps more of each dollar of sales as profit, with a net margin of −54.6% compared with −210% at CapsoVision.

CapsoVision scores higher on the StockData Score (6 against 2 for QT Imaging), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCVQTI
Size and price
Market cap$314M$30.2M
Share price$6.27$2.06
Change, 1 year15.2%−67.1%
Change, 5 years–−98.6%
Beta (5Y)−1.090.07
Employees9932
StockData Score
Total score6 (better)2
Valuation score00
Growth score01 (better)
Performance score00
Health score6 (better)1
Dividend score00
Valuation
P/S22.5×1.0× (better)
P/B11.9×11.4× (better)
FCF yield−9.3% (better)−46.8%
Fair value$1.28–
Margin of safety−391%–
Growth
Revenue growth (TTM)6.4%157% (better)
Profitability
Gross margin49.7% (better)40.2%
Operating margin−212%−24.9% (better)
Net margin−210%−54.6% (better)
FCF margin−210%−47.7% (better)
Return on equity−125%–
Return on invested capital−99.6%–
Financial health
Debt / equity0.001.47 (better)
Current ratio5.07 (better)2.78
Altman Z-score20.27 (better)−1.58
Piotroski F-score34 (better)
Dividends and buybacks
Buyback yield–−86.0%
Shareholder yield0.00% (better)−86.0%
Ownership
Held by institutions10.2%22.3%
Held by insiders29.0%91.5%
Insider net buying, 12 months$21.0M (better)$155K
Short interest, % of float5.5%–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.